Equities

Tissue Regenix Group PLC

TRX:LSE

Tissue Regenix Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)61.00
  • Today's Change-0.50 / -0.81%
  • Shares traded55.02k
  • 1 Year change1.67%
  • Beta1.9981
Data delayed at least 20 minutes, as of May 01 2024 16:34 BST.
More ▼

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Tissue Regenix Group PLC share price to rise to 120.00 in the next year from the last price of 61.50.
High95.1%120.00
Med95.1%120.00
Low95.1%120.00

Earnings history & estimates

Tissue Regenix Group PLC reported annual 2023 losses of -1.93 per share on Mar 19, 2024.
Average growth rate+51.82%
More ▼

Revenue history & estimates

Tissue Regenix Group plc had revenues for the full year 2023 of 23.72m. This was 19.34% above the prior year's results.
Average growth rate+17.13%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.